COVID-19 therapeutics information

Vaccination remains the number one defense against serious illness from COVID-19, and research tells us that recommendations from care providers is a critical factor in a patient’s decision to get vaccinated.

To support certain immunocompromised adults and pediatric individuals (12 years of age and older weighing at least 40 kg) who may not mount an adequate immune response we have updated our provider website with information on available therapeutics for COVID-19 (COVID-19 updates | Anthem Blue Cross in California). There is currently one treatment available for pre-exposure prophylaxis for COVID-19 (Evusheld), and several medications that are available for treatment of COVID-19. The currently available pre-exposure prophylaxis for COVID-19 is Evusheld (tixagevimab co-packaged with cilgavimab).

More information about Evusheld and the medical conditions and/or medications that allow an individual to qualify for Evusheld can be found on the Anthem provider website. If you would like Anthem to provide a list of your patients who are Medi-Cal members who might qualify for Evusheld, contact us at allison.lam@anthem.com.